Drugs / Magnesium Sulfate
last change 3 days ago re-read 2 minutes ago

Magnesium Sulfate

Other / unclassified

Developed for
preeclampsia · asthma · neuropathy, painful · atrial fibrillation · severe pre-eclampsia · cerebral palsy · chronic obstructive pulmonary disease · coronary artery disorder
+99 more · osteoarthritis, knee · acute asthma · breast cancer · ischemic stroke · myofascial pain syndrome · perinatal asphyxia · cardiac rhythm disease · delirium · magnesium deficiency · peripheral neuropathy · sickle cell disease · atrial flutter · bronchiolitis · childhood onset asthma · epilepsy · heart valve disorder · hypertensive disorder · intracerebral hemorrhage · major depressive disorder · migraine disorder · obesity disorder · pancreatitis · periventricular leukomalacia · pulmonary hypertension, neonatal · stroke disorder · traumatic brain injury · acute kidney injury · Alagille syndrome · alcohol withdrawal · alcohol-induced disorders · appendicitis · arterial disorder · autism spectrum disorder · benign prostatic hyperplasia · benign shuddering attacks · biliary atresia · bipolar I disorder · brain hypoxia - ischemia · brain injury · brain ischemia · bronchitis · cancer-related condition · cardiac arrest · carpal tunnel syndrome · chemotherapy-induced neuropathy · chemotherapy-induced toxicity · chronic pain syndrome · chronic rhinosinusitis · cluster headache syndrome · dyskinesia of esophagus · dysmenorrhea · eclampsia · female breast carcinoma · headache disorder · hypospadias · hypotensive disorder · ischemic disease · meningioma · migraine without aura · mixed anxiety and depressive disorder · muscle cramps, familial · myocardial infarction · noise induced hearing loss · non-small cell lung carcinoma · ocular hypertension · osteoporosis · pelvis syndrome · persistent fetal circulation syndrome · placenta praevia · placental abruption · poisoning · post-cardiac arrest syndrome · post-traumatic stress disorder · pregnancy disorder · sinusitis · status asthmaticus · subacute delirium · subarachnoid hemorrhage · temporomandibular joint disorder · thrombotic thrombocytopenic purpura · urinary system disorder · urinary tract obstruction · uterine disorder · acquired aneurysmal subarachnoid hemorrhage · aorta coarctation · autism spectrum disorder 1 · bone disorder · cisplatin toxicity · epicondylitis · hand, foot and mouth disease · hemorrhagic disease · intracranial vasospasm · mental disorder · obstetric disorder · peripheral ischemia · pharyngitis · preterm premature rupture of the membranes · thyroid cancer · tinnitus
Investigated by
Assiut University · Cairo University · Seoul National University Bundang Hospital · Ain Shams University · Mansoura University · Sohag University
+250 more · University Hospital, Clermont-Ferrand · Mahidol University · National Cancer Institute, Egypt · Seoul National University Hospital · The Hospital for Sick Children · University of British Columbia · Wake Forest University Health Sciences · Yonsei University · Children's Hospital Medical Center, Cincinnati · Fayoum University · Kasr El Aini Hospital · National Cancer Institute (NCI) · Tanta University · University of Monastir · University of Sao Paulo General Hospital · Ajou University School of Medicine · Al-Azhar University · Alberta Children's Hospital · Alexandria University · Alliance for Clinical Trials in Oncology · Aristotle University Of Thessaloniki · Assistance Publique - Hôpitaux de Paris · Bonsucesso Federal Hospital · Canadian Institutes of Health Research (CIHR) · Children's Hospital of Eastern Ontario · Chongqing Medical University · Christoph Czarnetzki · Complejo Hospitalario Dr. Arnulfo Arias Madrid · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Hamad Medical Corporation · Indonesia University · King Edward Medical University · Mayo Clinic · Medical University of Warsaw · Ministry of Health, France · NYU Langone Health · National Center for Research Resources (NCRR) · National Heart, Lung, and Blood Institute (NHLBI) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · National Institute of Neurological Disorders and Stroke (NINDS) · Nishtar Medical University · Queen's University · St. Justine's Hospital · Stanford University · Stollery Children's Hospital · The Second People's Hospital of Huai'an · Thomas Jefferson University · University Medicine Greifswald · University of Michigan · University of Sao Paulo · Wayne State University · Zagazig University · 900th Hospital of PLA Joint Logistic Support Force · AGUNCO Obstetrics and Gynecology Centre · Adebayo Joshua Adeniyi · Affiliated Yueqing Hospital of Wenzhou Medical University · Aga Khan University · AnestesiaR · Ankara City Hospital Bilkent · Ann & Robert H Lurie Children's Hospital of Chicago · Armed Forces Institute of Urology, Rawalpindi · Arsil Radiansyah · Astra USA · Autonomous University of Nuevo León · Avadim Technologies, Inc. · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · Baylor College of Medicine · Beni-Suef University · Beth Israel Medical Center · Bill and Melinda Gates Foundation · Brazilian National Cancer Institute · Brigham and Women's Hospital · CAMC Health System · Campus-Bio-Medico University · all 256 on the full record

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) TIS-U-SOL IN PLASTIC CONTAINER 1981-10-06 fda.gov

Trials 284 · started per year

today
US approved 1981
1
1
2
2
1
1
3
1
3
6
3
3
2
3
9
13
12
7
8
13
12
15
16
13
15
16
20
15
24
30
11
1981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 05 trials
Phase 0 NCT03879707 Jun 2025 → Jun 2028 Stanford University Withdrawn No outcome recorded
Phase 0 NCT06137040 Nov 2023 → May 2025 overdue acute asthma, childhood onset asthma University of Oklahoma Recruiting No outcome recorded
Phase 0 NCT05976464 Jul 2023 → Jul 2025 Assiut University Completed No outcome recorded
Phase 0 NCT04412850 Dec 2020 → Jun 2021 ischemic stroke Dow University of Health Sciences Unknown No outcome recorded
Phase 0 NCT04256057 Mar → Apr 2020 Beni-Suef University Unknown No outcome recorded
Phase 116 trials
Phase 1 NCT07677917 Jan → Jul 2026 overdue Ain Shams University Enrolling by invitation No outcome recorded
Phase 1 NCT07126795 Jan → Dec 2026 expected Hennepin Healthcare Research Institute Not yet recruiting No outcome recorded
Phase 1 NCT06956521 Jun 2025 → Jun 2026 overdue ischemic stroke Baylor College of Medicine Not yet recruiting No outcome recorded
Phase 1 NCT06455514 Mar 2025 → Mar 2026 overdue cardiac arrest, post-cardiac arrest syndrome NYU Langone Health Recruiting No outcome recorded
Phase 1 NCT06516861 Jan → Feb 2024 Arsil Radiansyah Completed No outcome recorded
Phase 1 NCT06209229 May 2022 → May 2023 non-small cell lung carcinoma MIPO Clinic Completed No outcome recorded
Phase 1 NCT05880693 Jan 2022 → Apr 2023 hypotensive disorder mohamed Completed No outcome recorded
Phase 1 NCT04929626 Jan → Nov 2022 status asthmaticus Ziauddin University Completed No outcome recorded
Phase 1 NCT04481672 Jul → Dec 2021 mesothelioma Dana-Farber Cancer Institute Completed No outcome recorded
Phase 1 NCT04941040 Jul → Oct 2021 supratentorial cancer Kasr El Aini Hospital Completed No outcome recorded
Phase 1/210 trials
Phase 1/2 NCT07131033 Sep 2025 → Jun 2026 gallbladder disorder The Second People's Hospital of Huai'an Completed No outcome recorded
Phase 1/2 NCT06920576 Mar → Jul 2025 overdue chronic rhinosinusitis The Second People's Hospital of Huai'an Active not recruiting No outcome recorded
Phase 1/2 NCT02709031 Jun 2022 → Jun 2024 diabetes mellitus, hypertensive disorder, potassium deficiency Navitas Pharma Unknown No outcome recorded
Phase 1/2 NCT05442931 May → Oct 2022 Minia University Unknown No outcome recorded
Phase 1/2 NCT04898114 Jun 2021 → Apr 2025 overdue pulmonary hypertension, neonatal Sohag University Recruiting No outcome recorded
Phase 1/2 NCT04328636 Nov 2017 → Jul 2020 persistent fetal circulation syndrome, pulmonary hypertension, neonatal Sohag University Completed No outcome recorded
Phase 1/2 NCT02602483 Dec 2015 → Dec 2016 temporomandibular joint disorder Spherium Biomed Completed No outcome recorded
Phase 1/2 NCT02296931 Mar → Oct 2015 preeclampsia William Marsh Rice University Completed No outcome recorded
Phase 1/2 NCT01502761 Mar 2012 → May 2016 stroke disorder University of Southern California Terminated No outcome recorded
Phase 1/2 NCT00500864 Aug 2004 → Nov 2007 chronic obstructive pulmonary disease University of Sao Paulo Completed No outcome recorded
Phase 229 trials
Phase 2 NCT07528612 Apr 2026 → Dec 2027 expected Region Halland Not yet recruiting No outcome recorded
Phase 2 NCT07458022 Dec 2025 → Apr 2026 overdue major depressive disorder University of Child Health Sciences and Children's Hospital, Lahore Active not recruiting No outcome recorded
Phase 2 NCT06975813 Jun → Dec 2025 overdue myofascial pain syndrome Fayoum University Not yet recruiting No outcome recorded
Phase 2 NCT07418671 May → Nov 2025 Ain Shams University Completed No outcome recorded
Phase 2 NCT05837104 Dec 2023 → Oct 2026 expected bipolar I disorder, mixed anxiety and depressive disorder Mclean Hospital Recruiting No outcome recorded
Phase 2 NCT05806996 Jul 2023 → Jun 2026 overdue Mayo Clinic Recruiting No outcome recorded
Phase 2 NCT05730816 Apr 2023 → Apr 2027 expected mesothelioma Brigham and Women's Hospital Recruiting No outcome recorded
Phase 2 NCT07081581 Aug 2022 → Feb 2023 breast cancer Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey Completed No outcome recorded
Phase 2 NCT04812028 Mar 2021 → Aug 2023 University of Minnesota Completed No outcome recorded
Phase 2 NCT04638881 Dec 2020 → Apr 2023 dyskinesia of esophagus Stanford University Completed No outcome recorded
Phase 2/312 trials
Phase 2/3 NCT07655817 Jul → Dec 2026 expected delirium, magnesium deficiency Tanta University Recruiting No outcome recorded
Phase 2/3 NCT06676475 Dec 2024 → Feb 2025 overdue myofascial pain syndrome Misr University for Science and Technology Not yet recruiting No outcome recorded
Phase 2/3 NCT05674565 Jan 2023 → Jun 2024 cerebral palsy Zagazig University Unknown No outcome recorded
Phase 2/3 NCT06168773 Nov 2022 → Oct 2023 delirium Ain Shams University Completed No outcome recorded
Phase 2/3 NCT04429893 Jan → Sep 2022 breast cancer, chronic pain syndrome Alexandria University Unknown No outcome recorded
Phase 2/3 NCT04740294 Jul 2021 → Nov 2025 bronchiolitis University of Louisville Withdrawn No outcome recorded
Phase 2/3 NCT02591004 Dec 2015 → Oct 2017 cerebral palsy Kasr El Aini Hospital Completed No outcome recorded
Phase 2/3 NCT02307201 Dec 2014 → Dec 2015 severe pre-eclampsia Complejo Hospitalario Dr. Arnulfo Arias Madrid Completed No outcome recorded
Phase 2/3 NCT02218424 Oct 2014 → Apr 2015 Ann & Robert H Lurie Children's Hospital of Chicago Completed No outcome recorded
Phase 2/3 NCT02317146 Nov 2013 → Dec 2016 severe pre-eclampsia Complejo Hospitalario Dr. Arnulfo Arias Madrid Completed No outcome recorded
Phase 341 trials
Phase 3 NCT07632157 Oct 2026 → Dec 2028 expected atrial flutter Wake Forest University Health Sciences Not yet recruiting No outcome recorded
Phase 3 NCT07524972 May 2026 → Apr 2028 expected cerebral palsy Cairo University Recruiting No outcome recorded
Phase 3 NCT06904287 Dec 2025 → Jun 2027 expected migraine disorder Wake Forest University Health Sciences Recruiting No outcome recorded
Phase 3 NCT06785272 Oct 2025 → Oct 2027 expected asthma Suzanne Schuh Recruiting No outcome recorded
Phase 3 NCT05049707 Nov 2024 → Oct 2025 brain neoplasm Thomas Jefferson University Unknown No outcome recorded
Phase 3 NCT06376916 Oct 2024 → Dec 2026 expected atrial fibrillation, atrial flutter Wake Forest University Health Sciences Recruiting No outcome recorded
Phase 3 NCT06306040 Apr → Nov 2024 delirium Assiut University Unknown No outcome recorded
Phase 3 NCT06026527 Mar → Sep 2024 Tribhuvan University Teaching Hospital, Institute Of Medicine. Completed No outcome recorded
Phase 3 NCT06626620 Jan → Sep 2024 acute asthma Muhammad Aamir Latif Completed No outcome recorded
Phase 3 NCT05021263 May 2022 → Dec 2023 colorectal cancer Thomas Jefferson University Completed No outcome recorded
Phase 480 trials
Phase 4 NCT07328893 Dec 2025 → Oct 2026 expected Tata Main Hospital Recruiting No outcome recorded
Phase 4 NCT07173855 Nov 2025 → Mar 2027 expected Scarborough General Hospital Recruiting No outcome recorded
Phase 4 NCT06745388 Jul 2025 → Sep 2026 expected uterine disorder Corewell Health East Recruiting No outcome recorded
Phase 4 NCT07076069 Jul 2025 → Jun 2028 expected rotator cuff syndrome Montefiore Medical Center Recruiting No outcome recorded
Phase 4 NCT06975072 Jul 2025 → Apr 2026 overdue University of California, San Francisco Recruiting No outcome recorded
Phase 4 NCT06997575 May → Nov 2025 eclampsia Nishtar Medical University Completed No outcome recorded
Phase 4 NCT05947760 Mar 2025 → Aug 2026 overdue neuropathy, painful University Hospitals Cleveland Medical Center Active not recruiting No outcome recorded
Phase 4 NCT06442995 Jan 2025 → Jul 2027 expected urinary tract obstruction Reims University Hospital Recruiting No outcome recorded
Phase 4 NCT06752525 Jan 2025 → Jan 2026 overdue sinusitis Assiut University Not yet recruiting No outcome recorded
Phase 4 NCT06743919 Jan 2025 → Jan 2026 Assiut University Completed No outcome recorded
Phase not applicable90 trials
NCT07675616 May → Dec 2026 expected lacrimal duct obstruction Cairo University Recruiting No outcome recorded
NCT07305519 Apr 2026 → Apr 2027 expected University of Roma La Sapienza Recruiting No outcome recorded
NCT07381036 Feb → Jul 2026 overdue Sohag University Not yet recruiting No outcome recorded
NCT07377903 Feb → Jul 2026 overdue Sohag University Not yet recruiting No outcome recorded
NCT07359560 Jan → Jul 2026 overdue female infertility Zagazig University Not yet recruiting No outcome recorded
NCT07390851 Nov 2025 → Nov 2026 expected myofascial pain syndrome Cairo University Recruiting No outcome recorded
NCT07258628 Oct 2025 → Jan 2026 cardiac rhythm disease, hypertensive disorder Ankara City Hospital Bilkent Completed No outcome recorded
NCT07310524 Sep → Nov 2025 Muhammad Rahman Efendi Nasution Completed No outcome recorded
NCT07082894 Jul 2025 → Apr 2026 Tanta University Completed No outcome recorded
NCT07521358 Jul → Aug 2025 major depressive disorder Hasanuddin University Completed No outcome recorded
Phase not stated1 trial
NCT01918514 State University of New York - Upstate Medical University No longer available No outcome recorded
Also used as a comparator or background therapy in 220 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 07 trials
Phase 0 NCT07252505 Comparator Nov 2025 → Oct 2027 expected Assiut University Not yet recruiting No outcome recorded
Phase 0 NCT06621004 Comparator Aug → Dec 2024 overdue Ain Shams University Enrolling by invitation No outcome recorded
Phase 0 NCT05880459 Comparator Aug 2023 → Nov 2024 Assiut University Unknown No outcome recorded
Phase 0 NCT04724655 Background Jan → Jun 2021 poisoning Tanta University Completed No outcome recorded
Phase 0 NCT04498351 Comparator Jun 2020 → Sep 2021 Cairo University Completed No outcome recorded
Phase 18 trials
Phase 1 NCT06702488 Comparator Nov 2024 → Apr 2025 overdue mental disorder Fayoum University Recruiting No outcome recorded
Phase 1 NCT06578000 Comparator Sep → Nov 2024 overdue epicondylitis NOUR ALI ABO EL ELAA FRAGHLY Recruiting No outcome recorded
Phase 1 NCT07248332 Comparator Jan 2024 → Sep 2025 acute cholecystitis Liaquat National Hospital & Medical College Completed No outcome recorded
Phase 1 NCT07248358 Comparator Jun 2023 → Sep 2025 acute cholecystitis Liaquat National Hospital & Medical College Completed No outcome recorded
Phase 1 NCT05119101 Comparator Mar 2022 → Oct 2023 preeclampsia Assiut University Unknown No outcome recorded
Phase 1/27 trials
Phase 1/2 NCT07079514 Comparator Jan → Apr 2025 Ziauddin University Completed No outcome recorded
Phase 1/2 NCT06486025 Comparator Jul → Sep 2024 severe pre-eclampsia Ain Shams University Unknown No outcome recorded
Phase 1/2 NCT06077539 Comparator Sep 2023 → Apr 2024 subacute delirium Cairo University Unknown No outcome recorded
Phase 1/2 NCT04688203 Comparator Feb → Sep 2021 peripheral ischemia Zagazig University Completed No outcome recorded
Phase 1/2 NCT02496676 Comparator May 2016 → Apr 2020 National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 224 trials
Phase 2 NCT06810765 Background Sep 2025 → Dec 2026 cognitive disorder, post-traumatic stress disorder, traumatic brain injury Johns Hopkins University Withdrawn No outcome recorded
Phase 2 NCT06811233 Background May 2025 → Aug 2029 expected acute myeloid leukemia M.D. Anderson Cancer Center Recruiting No outcome recorded
Phase 2 NCT06595017 Comparator Oct 2024 → Sep 2025 overdue myofascial pain syndrome Misr University for Science and Technology Not yet recruiting No outcome recorded
Phase 2 NCT06367595 Comparator Jun 2024 → Oct 2026 expected Assiut University Not yet recruiting No outcome recorded
Phase 2 NCT05663801 Comparator Dec 2022 → Dec 2023 breast cancer Beni-Suef University Completed No outcome recorded
Phase 2/324 trials
Phase 2/3 NCT06956950 Comparator May → Oct 2025 overdue Tanta University Recruiting No outcome recorded
Phase 2/3 NCT06721247 Comparator Nov 2024 → Nov 2025 overdue asthma Zagazig University Active not recruiting No outcome recorded
Phase 2/3 NCT06427707 Comparator Jun → Oct 2024 overdue esophageal varices with bleeding Ain Shams University Recruiting No outcome recorded
Phase 2/3 NCT06148168 Comparator Jan 2024 → Jan 2025 Assiut University Unknown No outcome recorded
Phase 2/3 NCT06131905 Comparator Jan 2024 → Jan 2025 magnesium deficiency Assiut University Unknown No outcome recorded
Phase 337 trials
Phase 3 NCT07652801 Comparator Jul → Dec 2026 expected brain hypoxia - ischemia University of Child Health Sciences and Children's Hospital, Lahore Not yet recruiting No outcome recorded
Phase 3 NCT07443163 Comparator Mar → Sep 2026 expected Cairo University Not yet recruiting No outcome recorded
Phase 3 NCT07326397 Comparator Feb 2026 → Nov 2027 expected Assiut University Not yet recruiting No outcome recorded
Phase 3 NCT07220902 Comparator Jan 2026 → Dec 2033 expected severe pre-eclampsia Nebraska Methodist Health System Not yet recruiting No outcome recorded
Phase 3 NCT07213037 Comparator Nov 2025 → Nov 2026 expected Assiut University Not yet recruiting No outcome recorded
Phase 444 trials
Phase 4 NCT07478055 Comparator Jun 2026 → Jun 2027 expected severe pre-eclampsia Alexander Harrison Not yet recruiting No outcome recorded
Phase 4 NCT06966102 Comparator May → Jul 2025 overdue Cairo University Not yet recruiting No outcome recorded
Phase 4 NCT06317597 Comparator Mar → Dec 2024 Changhai Hospital Unknown No outcome recorded
Phase 4 NCT05855798 Comparator May → Oct 2023 Cukurova University Completed No outcome recorded
Phase 4 NCT05714540 Comparator Feb → Aug 2023 pharyngitis Beni-Suef University Unknown No outcome recorded
Phase not applicable69 trials
NCT07438366 Comparator Feb → Nov 2026 expected myofascial pain syndrome South Egypt Cancer Institute Not yet recruiting No outcome recorded
NCT07199595 Comparator Oct 2025 → Oct 2026 expected Assiut University Not yet recruiting No outcome recorded
NCT07181564 Comparator Sep 2025 → Feb 2026 overdue brain ischemia University General Hospital of Patras Recruiting No outcome recorded
NCT07105618 Comparator Aug 2025 → Aug 2026 overdue Zagazig University Recruiting No outcome recorded
NCT06717490 Comparator Dec 2024 → Nov 2025 overdue Marianna Mavromati Recruiting No outcome recorded

Evidence & citations 26 cited values

Every value below carries the sentence it was read from. 523 sources stand behind the page.

FieldValueCited text
Known as magnesium sulfate “Ketamine and magnesium group (group KM): will receive a bolus of 0.5 mg/kg ketamine added to 50mg/kg magnesium sulfate diluted in 100 ml normal saline over 30 minutes after...” NCT04111848
331

“One of these adjuvants is magnesium sulfate which is used in combination with local anaesthetics to help reduce onset of effect, prolong the duration of action and to increase...” NCT07451327

“This is a phase I trial that aims to demonstrate safety and feasibility of administering cold saline, minocycline, and magnesium sulfate intra-arterially immediately after...” NCT05032781

“In experimental models, magnesium sulfate increases cleavage of newly released vWF by ADAMTS13, decreases the endothelial secretion of ultralarge vWF and inhibits the...” NCT03237819

“Trans-foraminal Lumbar Epidural Injection of Dexmedetomidine Against Magnesium Sulfate When Combined With Dexamethasone in Uni-lateral Lower Limb Radicular Pain. Multi-centeric...” NCT05271721

“Therefore we decided to compare the effect of intravenous injection of magnesium sulfate and lidocaine on the prevention of laryngospasm occurrence, and analgesic requirement...” NCT06761547

“Half of the patients (selected randomly using random number table) will receive 150mg of magnesium sulfate in the block and the other half will receive 300 mcg of buprenorphine...” NCT05091138

“A separate mixture of glucose 25% (A.N.B Laboratories, Thailand) 50 mL, potassium chloride (Nida pharma, Thailand) 20 mEq and magnesium sulfate (Atlantic, Thailand) 2 gm was infused” NCT01225159

Magnesium sulfate (MgSo4) blocks N-methyl-d-aspartate receptors, and that is why, it was used as an adjuvant to the local anesthetic (LA) in different anesthetic approaches.” NCT05158647

“There are many tocolytic agents may have a role in conservative management of placenta previa such as magnesium sulfate, calcium channel blockers and β-sympathormimetics.” NCT03542552

“Therefore, we designed a prospective randomized controlled trial to compare the analgesic efficacy of combining magnesium sulfate with bupivacaine in QLB.” NCT06301789

“The patient will receive magnesium sulfate 40 mg/kg infuse over 30 min started at skin incision and continuous drip 10 mg/kg/hr until the dura is closed” NCT03558516

Magnesium sulfate is one of the most effective adjuvant drugs with the least side-effect profile in the treatment of tremor after noxial block.” NCT05427149

“Ultrasound-guided suprascapular nerve block will be performed using 7 mL of 0.5% bupivacaine plus magnesium sulfate 10% (3 ml) (total 10mL)” NCT03602469

Magnesium Sulfate: Used as an IV loading dose at 20 mg/kg IV over 17 minutes as an induction agent, followed by maintenance of 10 mg/kg/h” NCT07199595

“Multimodal Intravenous Analgesia Using Half-dose of Ketamine, Lidocaine and Magnesium Sulfate Provides Efficient Postoperative Analgesia” NCT06661746

“The active comparator is composed of clonidine 1 microg/kg combined with magnesium sulfate 40 mg/kg diluted in 45 ml of sodium chloride” NCT04436250

“Peroperative opioid free anesthesia will be obtained via a combination of dexmedetomidine, ketamine, lidocaine and magnesium sulfateNCT03124680

“2ml MgSo4 (Magnesium sulfate sterile ampoule 10 ml, 100 mg/ml = 0.41 mMol/ml. Egyptian Int. Pharmaceutical Industries Co., Egypt).” NCT06676475

“Half of the patients (selected randomly using random number table) will receive 150mg of magnesium sulfate (0.3mL) in the block” NCT05004636

magnesium sulfate (MgSO4) improved outcomes in children with HFMD if used earlier in the evolution of the ANS dysregulation” PMID 31438878 Aug 2019

Magnesium sulfate (MGS) is a non-competitive antagonist of N-methyl, D-aspartate (NMDA) receptors with an analgesic effect” NCT04391855

magnesium sulfate 4 g intravenous infusion (IVI) in 1st day (diluted in 50 ml D5W over 24 hours) then 2g IVI over 24 hours” NCT06168773

“100 women with severe preeclanpsia received Magnesium sulfate 6 grams intravenous over 20 minutes as a loading dose.” NCT03891498

“Group B received 30 ml levobupivacaine (0.25%) plus 50 mg/kg magnesium sulfate in the same pattern as in the A group” NCT05281081

“magnesium group (30 patients) who will receive pretreatment by intravenous infusion of magnesium sulfate 60 mg / kg” NCT02989272

“The study group (OFA group) will receive a combination of clonidine, magnesium sulfate, ketamine, and lidocaine.” PMID 34838109 Nov 2021

“50 patients will receive preoperative nebulization with 250 mg magnesium sulfate in 5 ml normal saline.” NCT07381036

“Women received 4 g of a 0.1 g/ml magnesium sulfate solution or isotonic serum chloride solution (0.9%).” NCT00120588

Magnesium sulfate is considered a neuroprotective drug and has been studied in various applications.” NCT06702488

“Received IV magnesium sulfate (50 mg/kg up to a maximum dose of 2 g) administered over 20 minutes” NCT06626620

“The active ingredient in Theraworx foam is magnesium sulfate and will not be in the placebo foam.” NCT04017390

“The patients in group 1 (n = 20) will receive a dose of magnesium sulfate (65 mg) po twice daily.” NCT01541111

Magnesium sulfate (MgSO4) is the most widely accepted eclampsia treatment and prophylactic agent” NCT00293735

“It is composed by Dexmedetomidine (Dexdor), Lidocaine, Magnesium Sulfate and ketamine (Ketolar).” NCT05887258

“OFA (n=159) consisting of intravenous ketamine, dexamethasone, lidocaine, and magnesium sulfatePMID 42190101 May 2026

magnesium sulfate as an N-methyl-D-aspartate (NMDA) receptor antagonist to enhance analgesia” NCT07310524

“intra-articular injection with magnesium sulfate with four injections at weekly intervals” NCT03675659

Magnesium Sulfate in Combination With Dexmedetomidine As Adjuvants to Levobupivacaine” NCT04498351

“bupivacain 0.125% magnesium sulfate 5%) infusion in the presternum , for 48 hours” NCT03230227

“one group receiving magnesium sulfate and the other receiving normal saline” NCT06717490

“IV magnesium sulfate, used to replete magnesium stores” NCT05021263

Magnesium sulfate (MgSO4) has anti-shivering effects.” NCT03008850

“40 mg/kg magnesium sulfate in 100 ml N/S infusion” NCT05752799

“40 mg/kg Magnesium sulfate in 100 ml N/S infusion” NCT07568938

“5 g of magnesium sulfate (Ketamine + magnesium)” NCT02450214

“antiarrhythmic agents as Magnesium sulfateNCT04724655

“Intravenous magnesium sulfateNCT02455687

Magnesium SulfateNCT03632590

NCT00560092

NCT07445451

NCT05287191

NCT04938765

NCT05049707

NCT01113138

NCT02453373

NCT04812028

NCT02833038

NCT06603766

NCT05644873

NCT02467517

NCT00998738

NCT05227716

NCT03458078

NCT01429415

NCT06920576

NCT02514343

NCT03318211

NCT04613960

NCT05237791

NCT03296579

NCT05880693

NCT02731950

NCT05880732

NCT04328636

NCT03595397

NCT00423540

NCT04576364

NCT06442995

NCT04898114

NCT05674565

NCT00811057

NCT02307201

NCT04705948

NCT06317597

NCT07390851

NCT07418580

NCT03703349

NCT01389791

NCT07220902

NCT04465175

NCT05976464

NCT02100293

NCT03846284

NCT04330755

NCT06026527

NCT04814381

NCT01938300

NCT00500864

NCT06367595

NCT04695613

NCT03460041

NCT02087202

NCT05826119

NCT03208452

NCT03262857

NCT02820610

NCT05340803

NCT07252505

NCT05099250

NCT05186467

NCT05005494

NCT06979141

NCT01515995

NCT02669368

NCT01843296

NCT06306040

NCT03695640

NCT05110469

NCT03661775

NCT00522444

NCT06376916

NCT01426165

NCT07328893

NCT05828966

NCT04646876

NCT01342510

NCT04166877

NCT05829317

NCT04599868

NCT06879288

NCT01804205

NCT04645719

NCT01682499

NCT05967442

NCT04223219

NCT01601314

NCT03298191

NCT00059332

NCT07258628

NCT00186069

NCT04078659

NCT07131033

NCT05671081

NCT06966518

NCT03199924

NCT00185900

NCT06342362

NCT04539379

NCT02581683

NCT03542552

NCT06414356

NCT00344058

NCT02185859

NCT06677827

NCT06743919

NCT05343806

NCT02533284

NCT02164773

NCT04776369

NCT01918514

NCT05166811

NCT01099449

NCT01828385

NCT00116623

NCT04464005

NCT00316914

NCT03253224

NCT06516861

NCT05520021

NCT02932254

NCT06955559

NCT04003688

NCT01440933

NCT04234906

NCT06513013

NCT03343548

NCT05345132

NCT02317146

NCT04903743

NCT01950520

NCT06445829

NCT01584726

NCT05565664

NCT05325580

NCT02483611

NCT02835339

NCT07081581

NCT07173855

NCT07438366

NCT02145520

NCT03925025

NCT01197417

NCT07460115

NCT05669417

NCT04514731

NCT03749590

NCT04300985

NCT02728037

NCT03439358

NCT07443163

NCT01136421

NCT03206008

NCT05442931

NCT07248540

NCT01383655

NCT01433081

NCT01794247

NCT07181564

NCT07478055

NCT02506894

NCT05119101

NCT05653401

NCT06180941

NCT06956950

NCT07655817

NCT00004730

NCT01597557

NCT00965874

NCT04360473

NCT01923831

NCT00004399

NCT02499393

NCT05003765

NCT00463736

NCT06137040

NCT05624151

NCT02928315

NCT05743725

NCT01032213

NCT02680626

NCT04497766

NCT06126068

NCT06956521

NCT06848595

NCT02496676

NCT01408979

NCT06811233

NCT04651556

NCT04929626

NCT04005599

NCT02198547

NCT06728839

NCT01795495

NCT01956981

NCT03617289

NCT01945437

NCT06745388

NCT06455514

NCT05261516

NCT02498496

NCT01856959

NCT03717467

NCT02296931

NCT07377903

NCT06685705

NCT03541915

NCT01479751

NCT01911494

NCT05850832

NCT01333488

NCT00313963

NCT00065949

NCT06563349

NCT03164304

NCT07213037

NCT06815887

NCT06477133

NCT04275661

NCT00124150

NCT04688203

NCT00306462

NCT05855798

NCT03729973

NCT04638881

NCT06578000

NCT03067896

NCT05554848

NCT01460563

NCT03479216

NCT04561921

NCT04161729

NCT00632606

NCT00007033

NCT04144933

NCT01241175

NCT04013243

NCT05418114

NCT07433231

NCT01522040

NCT04510337

NCT07524972

NCT04554862

NCT01502761

NCT07359560

NCT04256057

NCT05858957

NCT04767633

NCT06975072

NCT00002146

NCT05090761

NCT05707962

NCT02235246

NCT05663801

NCT00014989

NCT05730816

NCT02912663

NCT02826746

NCT04617652

NCT04249804

NCT04740294

NCT04481672

NCT03289429

NCT07632157

NCT03725228

NCT02940509

NCT06427707

NCT02396030

NCT03020706

NCT06131905

NCT02930707

NCT02584738

NCT04412850

NCT01799109

NCT07126795

NCT03497923

NCT02091401

NCT04544163

NCT06491485

NCT06785272

NCT04742140

NCT01743144

Known as Eziclen “Natrium/ Kalium/ Magnesium sulfate ( Eziclen™, oral solution) 1 L in the evening before colonoscopy” NCT03698474
Known as IVMg “Children managed for asthma in an emergency department (ED) may be less likely to be hospitalized if they receive intravenous magnesium sulfate (IVMg).” PMID 37459153 Jul 2023
Known as Magesium sulphate “Patients in group A will receive Magesium sulphate 4 gm intravenous (I.V) loading dose over 30 mins” NCT02591004
1

NCT02591004

Known as magnesium “This study proposes a randomized, double-blind, placebo-controlled crossover trial to assess the effects of a prophylactic combination of N-acetylcysteine (600 mg) and...” PMID 24708640 Apr 2014
65

“Anesthesia will be maintained with Sevoflurane, Magnesium, Lidocaine, Ketamine, Decadron, Ondansetron, and Ketorolac at a concentration range/dose(s) based on the clinical need...” NCT03367988

“In addition to propofol as a hypnotic and rocuronium as a muscle relaxant, patients in the opioid-sparing group will receive Ketamine, Fentanyl, Lidocaine, Magnesium,...” NCT05485480

“Intraoperatively: Intravenous Dexamethasone 0.1mg/kg (maximum dose of 8mg), Magnesium 2g, Acetaminophen 1000mg, and local infiltration of 0.5% Ropivacaine 20ml” NCT07076069

“The study aims to investigate whether a commonly used medicine, magnesium, can help reduce pain after a Caesarean section.” NCT07528612

Magnesium supplementation administered orally at a dose of 350 mg once daily as adjunct therapy to fluoxetine for 6 weeks.” NCT07521358

“A bolus dose of magnesium of 50 mg/kg will be administered within 10 minutes preoperatively diluted in 100 mL of saline.” NCT04622904

Magnesium (in the form of lactate dihydrate) 470 mg + pyridoxine (in the form of hydrochloride) 5 mg - take orally” NCT06209229

“Triple combination of Ibuprofen, Magnesium and Vitamin C Powder for oral solution administered TID for 3 days” NCT03223519

Magnesium 50mg (Magnesium 10% 0.5mL)added to ropivacaine 0.15% 1.0ml/kg to Group MR.” NCT01679353

“a supplementation with potassium and magnesium will be orally given” NCT01146197

Magnesium plus alpha-lipoic acid” NCT02016495

“Dietary Supplement: MagnesiumNCT02982824

NCT01148888

NCT04532775

NCT00041392

NCT03063931

NCT03879707

NCT00323583

NCT01756209

NCT04747171

NCT07305519

NCT00276146

NCT04603638

NCT00346658

NCT02018276

NCT05947760

NCT00029510

NCT00242164

NCT06966102

NCT05586009

NCT04626063

NCT00325299

NCT05837104

NCT07147972

NCT02709031

NCT04509401

NCT06810765

NCT01700998

NCT01121653

NCT02508857

NCT00994981

NCT03355807

NCT02602483

NCT03963479

NCT07082894

NCT05488847

NCT00000610

NCT06904287

NCT00142233

NCT00525317

NCT05806996

NCT03033823

NCT05851768

NCT00250965

NCT00641784

NCT07458022

NCT02334059

NCT03082625

NCT06077539

NCT05149820

NCT01087658

NCT02218424

NCT06721247

NCT03132701

NCT00808470

Known as Magnesium group ClinicalTrials.gov intervention name — accepted as the source's own label NCT07528612
Known as Magnesium SO4 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03322878
Known as Magnesium Sulfate Injection 50% Baxter. Number 5430 Magnesium Sulfate Injection 50% Baxter. Number 5430NCT02498496
Known as Magnesium Sulfate Sandoz “Each treatment will utilize 600 mg (1.2 mL) of Magnesium Sulfate SandozNCT01429415
Known as Magnesium Sulfate, Heptahydrate “Drug: Magnesium Sulfate, HeptahydrateNCT05166811
Known as magnesium sulphate “Group IV (n=30) will receive intravenous (IV) 20 ml magnesium SO4 (50 mg/ kg 10% MgSO4(magnesium sulphate) diluted in normal saline to a total volume of 20 ml(milliliter) ) and...” NCT03322878
117

“Patients received 40 mg/kg of magnesium sulphate infusion in 100cc normal saline, as a bolus dose, in addition to 0.2mg/kg of ketamine as a bolus dose, 15 min before the...” NCT04095455

Magnesium sulphate is an intracellular cation with various physiologic functions such as enzyme activation, nerve signal conduction, protein synthesis and vasomotor tonicity regulation.” NCT03008850

“Pre loading fluid with Magnesium sulphate 16 milliequivalent plus potassium chloride 20 milliequivalent in Normal saline 500 ml IV drip in 4 hours before Cisplatin administration” NCT02481518

“The present study will examine the effect of administering intravenous magnesium sulphate during anesthesia in patients undergoing elective laparoscopic cholecystectomy surgery.” NCT05598307

“A previously published study suggested that pre-treatment with magnesium sulphate (MgSO(4)) had no impact on the speed of onset of rocuronium-induced neuromuscular block.” PMID 19919585 Nov 2009

“The patients receive 20 ml plain bupivacaine(0.5%)+200 milligram magnesium sulphate (2 ml of magnesium 10%) in adductor canal block after spinal anesthesia.” NCT04892420

Magnesium sulphate, an antagonist of N-methyl-D-aspartate (NMDA) glutamate receptors, has been reported to improve hypo-magnesia and pre-eclampsia.” NCT06306040

Magnesium Sulphate will be given as doses of 20-50mg/kg in 2 -3 minutes. In order to standardize the dose in every patient we will be using 3g” NCT07079514

“whereas magnesium sulphate (MgSo4) group were given loading dose 40 mg/kg over 15 mins then maintenance dose 15 mg/kg/h till end of surgery.” NCT05850832

Magnesium sulphate will be administered at a dose of 6g over 20 min intravenously followed by a continuous infusion of 6g / 24h for 3 days.” NCT03237819

Magnesium Sulphate as a drug has been in clinical use for decades; its pharmacokinetics, safety profile and mode of action are well known.” NCT05707962

“1ml/kg of the study solution containing 60 mg/ml of magnesium sulphate are given intravenously over 15 minutes in the conscious patient.” NCT01440933

“Role of Magnesium Sulphate as an Adjuvant to Bupivacaine in U.S Guided Quadratus Lumborum Block in Lower Abdominal Cancer Surgeries” NCT06301789

Magnesium sulphate (MgSO4) is a drug that is routinely used in the treatment of preeclampsia and prevention of eclamptic fits.” NCT05119101

“To introduce Magnesium sulphate as cheap effective alternative for prevention and management of post-spinal opioid pruritis.” NCT04160598

“There is little information on the interaction between magnesium sulphate (MgSO4) and rocuronium in elderly patients.” PMID 23635996 Oct 2013

Magnesium sulphate was administered by continuous intravenous infusion according to our hospital protocol as follows:” NCT03237000

“The patient receives during 15 minutes a perfusion of 60mg/kg of Magnesium sulphate before induction of anaesthesia.” NCT01571908

“patients received an IV magnesium sulphate bolus and infusion 40 mg/kg starting just before and during anesthesia” NCT04695613

Magnesium sulphate has a calcium antagonist property, which provides muscle relaxation and increases flaccidity.” NCT06761547

“One infusion of intravenous Magnesium Sulphate intra-operatively as an analgesic, 50mg/kg given over 30minutes.” NCT03859102

“compare between analgesic effect of magnesium sulphate versus dexmedetomidine as an adjuvant to bupivacaine” NCT05577260

“We hypothesized that intrathecal dexmedetomidine and magnesium sulphate (MgSO4 ) may add similar effects.” PMID 31461801 Sep 2019

Magnesium sulphate is the drug of choice for the prevention and treatment of women with eclampsia.” PMID 37815037 Oct 2023

“Patients will receive 40 mg/kg of IV magnesium sulphate (equivalent to 0.4 ml/kg) over 10 min.” NCT05565664

“Group BMG (n =26): received bupivacaine 30 mL 0.25% and 500 mg magnesium sulphate.” NCT05565235

Magnesium sulphate is probably effective in delaying preterm birth by 48 hours” PMID 35947046 Aug 2022

“Rocuronium 0.6-1.2mg/kg, Magnesium sulphate 2.5-5g and Dexamethasone 8-16mg” NCT04894864

Magnesium sulphate (MgSO4) is regularly used in perioperative medicine.” NCT03497923

Magnesium sulphate is used extensively in the treatment of eclampsia” PMID 17042843 Nov 2006

Magnesium sulphate according to weight will be given intravenously.” NCT04497766

Magnesium sulphate as an adjunct to total intravenous anesthesia.” NCT07105618

“Evidence supported magnesium sulphate as the drug to evaluate.” PMID 12057549 Jun 2002

“masseter muscle trigger points injection by magnesium sulphateNCT06975813

Magnesium sulphate (MgSO4) 10% solution is going to be used” NCT01743144

“Investigational Product and Planned Use Magnesium sulphateNCT05287191

“28 ml bupivacaine 0.25% + 2 ml magnesium sulphate (200mg)” NCT03957499

“Bupivacaine Magnesium sulphate group” NCT05397236

“0.18 mL of 10% magnesium sulphateNCT04561921

“B: Magnesium sulphateNCT05743725

Magnesium sulphateNCT03344679

NCT03640390

NCT04539249

NCT05880459

NCT01542697

NCT01646619

NCT03979599

NCT07675616

NCT03643666

NCT01492608

NCT01049464

NCT06626620

NCT07418671

NCT06486025

NCT07326397

NCT07677917

NCT01205997

NCT03344679

NCT01972659

NCT07544173

NCT06717490

NCT07139522

NCT04393610

NCT04429893

NCT02619799

NCT02008747

NCT03393572

NCT02678117

NCT03612947

NCT02752334

NCT07451327

NCT02487355

NCT05294393

NCT00553072

NCT06595017

NCT04987372

NCT03854812

NCT05837000

NCT02647268

NCT03810209

NCT05659212

NCT02359370

NCT06087211

NCT03566329

NCT06675500

NCT06085417

NCT04260659

NCT07248358

NCT05699720

NCT02112305

NCT07248332

NCT07113782

NCT06180031

NCT06468475

NCT00405977

NCT06997575

NCT06752525

NCT03112551

NCT01261702

NCT05164627

NCT03461328

NCT04320589

NCT05714540

NCT03722940

NCT01153256

NCT03548493

NCT02309879

NCT04498351

NCT06621004

NCT03106818

NCT06977425

NCT05757999

NCT02684019

NCT01940250

NCT04501289

NCT02699827

NCT06612996

Known as magnesuim sulfate “epidural transforaminal injection of magnesuim sulfateNCT05271721
Known as magnesuim sulphate “Group M: (magnesuim sulphate group)” NCT05577260
Known as Magnezyum Sulfat %15 “25 mg MgSO4 (Magnezyum Sulfat %15, Biofarma, Istanbul, Turkey)” NCT05427149
Known as Magnogene Magnogene ® (magnesium)” NCT01121653
Known as Magnésium UPSA Action Continue “Magnesium: Magnésium UPSA Action Continue®” NCT03063931
Known as Magphate “Group A: will receive 4g of 20% intravenous (I.V.) MgSO4 (Magphate®) given over 10 minutes, followed by 3g of 50% intramuscular (I.M.) MgSO4 in each buttock statim.” NCT04501289
Known as Mg sulfate “The aim of this study is to assess the efficacy of Mg sulfate ( 10% ) as an adjuvant to Bupivacain ( 0.25 % ) in an U.S guided QLB for postoperative analgesia and postoperative...” NCT06301789
2

“Eligible consenting children will receive three experimental treatments of nebulized salbutamol with either 600 mg of Mg sulfate or placebo 20 min apart” PMID 27220675 May 2016

“. 200 mg Mg sulfate (1ml) plus 4 mg dexamethasone(1ml) plus 40mg lidocaine 2% (2ml)” NCT05271721

Known as MGS “Magnesium sulfate (MGS) is a non-competitive antagonist of N-methyl, D-aspartate (NMDA) receptors with an analgesic effect” NCT04391855
Known as MgSO4 “BACKGROUND: Succinylcholine remains the muscle relaxant of choice for rapid sequence induction (RSI) but has many adverse effects. High-dose rocuronium bromide may be an...” PMID 33337797 Dec 2021
58

“Magnesium sulfate (MgSO4) will be administered intravenously at induction of anesthesia as a 30-minute bolus dose of 50 mg/kg (maximum 2 grams) in the OR, followed by a 15...” NCT04812028

“Group IV (n=30) will receive intravenous (IV) 20 ml magnesium SO4 (50 mg/ kg 10% MgSO4(magnesium sulphate) diluted in normal saline to a total volume of 20 ml(milliliter) ) and...” NCT03322878

“After pre-treatment with a clinically relevant dose of magnesium sulphate (MgSO4), an increased speed of onset and a prolongation of the recovery period of the neuromuscular...” NCT01440933

“Magnesium sulfate (MgSO4) is an N-Methyl D-Aspartate (NMDA) receptor antagonist that has been used for postoperative analgesia and reducing both the duration and intensity of...” NCT05880732

“Group 3: IA cold saline + Minocycline + Magnesium sulfate 3-6 patients receive IA cold saline + MTD Minocycline + 2g MgSO4; 3-6 patients receive IA cold saline + MTD...” NCT05032781

“foetal neuroprotection will be administered consisting of MgSO4 in an intravenous loading dose of 4 g (administered slowly over 20-30 min), followed by a 1 g per hour maintenance dose.” NCT07107477

“Magnesium sulfate (MgSo4) blocks N-methyl-d-aspartate receptors, and that is why, it was used as an adjuvant to the local anesthetic (LA) in different anesthetic approaches.” NCT05158647

“compare between effect of nebulized and intravenous magnesium sulfate (MgSO₄) for better treatment of persistent pulmonary hypertension of neonates with less side effects.” NCT06603766

“In the Mg group, 30 mg/kg of 10% MgSO4 solution was administered intravenously for over 20 minutes as the loading dose, followed by the continuous infusion of 10 mg/kg/hr” PMID 32770840 Aug 2020

“A previously published study suggested that pre-treatment with magnesium sulphate (MgSO(4)) had no impact on the speed of onset of rocuronium-induced neuromuscular block.” PMID 19919585 Nov 2009

“The del Nido components are: Plasma-Lyte A (1000ml), Mannitol 20% (16.3ml), MgSO4 50% (4ml) , NaHCO3 8.4% (13ml) , KCl 2mEq/mL (13ml), Lidocaine 1% (13ml).” NCT03818126

“This study aimed to compare the cerebral hemodynamic effects of magnesium sulfate (MgSO4) and labetalol in pre-eclampsia patients with severe features.” PMID 37074522 Apr 2023

MgSO4 100mg in 20 ml normal saline will be given via ultrasonic nebulizer over 10 minutes,and PAS score will be assessed at 30,60,120,240,360 minutes” NCT04497766

“Patients received magnesium sulfate (MgSO4 group, 150 mg in 4 mL of normal saline)delivered via aerosol mask at 10 L/min driven by pressurised air.” NCT01136421

“whereas magnesium sulphate (MgSo4) group were given loading dose 40 mg/kg over 15 mins then maintenance dose 15 mg/kg/h till end of surgery.” NCT05850832

“The rational of using magnesium sulphate MgSo₄ infusion to control catecholamine levels \& catecholamine-related crisis has been established” NCT04320589

“Magnesium sulphate (MgSO4) is a drug that is routinely used in the treatment of preeclampsia and prevention of eclamptic fits.” NCT05119101

“Magnesium sulphate (MgSO4), N-methyl-D-aspartate receptor antagonist has the potential to be an ideal adjuvant in TAP block.” NCT03612947

“Magnesium sulfate (MgSO4) may enhance the effects of local anesthetics when used as an adjuvant in peripheral nerve blocks.” PMID 37719936 Sep 2023

“There is little information on the interaction between magnesium sulphate (MgSO4) and rocuronium in elderly patients.” PMID 23635996 Oct 2013

“100 ml normal saline containing MgSO4 30 mg/kg infused over 10 min immediately before the induction of anesthesia” NCT05186467

“Magnesium sulfate (MgSO4) may be useful in preventing neurological injury after subarachnoid haemorrhage (SAH).” PMID 16463861 2005

“Participating children received IV MgSO4 (100 mg/kg) every 8 hours or placebo in addition to standard therapy.” PMID 24276838 Nov 2013

“We hypothesized that intrathecal dexmedetomidine and magnesium sulphate (MgSO4 ) may add similar effects.” PMID 31461801 Sep 2019

“Magnesium sulfate (MgSO4) is certainly the ideal drug for prevention and control of eclamptic seizures.” NCT01408979

“Magnesium sulfate (MgSO4) is the most widely accepted eclampsia treatment and prophylactic agent” NCT00293735

“Magnesium sulfate (MgSO4) may be helpful as an analgesic adjuvant in regional anesthesia” NCT05671081

“12-hour and 24-hour postpartum magnesium sulfate (MgSO4) therapy for mild preeclampsia” PMID 17012443 Oct 2006

“Magnesium sulfate (MgSO4) has multiple desirable effects in an anesthetic procedure” NCT05227716

“Magnesium Sulfate (MgSO4) is a N-Methyl-D-aspartate (NMDA) receptor antagonist” NCT05653401

“Magnesium sulfate (MgSO4) and sodium bicarbonate (NaHCO3) were added to” PMID 36856693 Mar 2023

“Magnesium sulphate (MgSO4) is regularly used in perioperative medicine.” NCT03497923

“Mg SO4 loading dose 30 mg/kg i.v. infusion in 100 ml over 10 minutes.” NCT04941040

“25 mg MgSO4 (Magnezyum Sulfat %15, Biofarma, Istanbul, Turkey)” NCT05427149

“D5 NS (665 ml/m2) + KCl (2 mEq/100 ml) +MgSO4 (0.5 mEq/100 ml)” NCT00042367

“Magnesium sulphate (MgSO4) 10% solution is going to be used” NCT01743144

“Bupivacaine plus Magnesium Sulphate (MgSO4) as adjuvant” NCT07418671

“Magnesium sulfate (MgSO4) has anti-shivering effects.” NCT03008850

“Intravenous (IV) magnesium sulfate (MgSO4)” NCT02496676

“intravenous magnesium sulfate (MgSO4)” NCT00065949

“Magnesium sulfate (MgSO4) infusion” NCT07433231

“inhaled magnesium sulfate (MgSO4)” NCT06955559

“Drug: MgSO4NCT06676475

NCT05158647

NCT03318471

NCT05736744

NCT04705142

NCT04632524

NCT01025245

NCT01846156

NCT04401852

NCT03237000

NCT02538718

NCT07652801

NCT06148168

NCT06720337

NCT07075783

NCT05609955

Known as MgSO₄ heptahydrate “a 10% intravenous preparation of MgSO₄ heptahydrate with sterile distilled water” NCT06603766
Known as Natrium/ Kalium/ Magnesium sulfate ClinicalTrials.gov intervention name — accepted as the source's own label NCT03698474
Known as Sulfate, Magnesium “Drug: Sulfate, MagnesiumNCT03237819
1

“Drug: Sulfate, MagnesiumNCT02989272

Action Inhibit “Magnesium is considered to be "nature's physiologic calcium blocker."” NCT00000610
Modality Other / unclassified “As a physiological blocker of NMDAR, magnesium could be an interesting candidate to prevent postoperative pain and associated comorbidities, including cognitive and emotional...” PMID 30287600 Oct 2018